UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045578
Receipt number R000051988
Scientific Title Long-term functional prognostic study of Coronavirus disease - 2019 (COVID-19) infection
Date of disclosure of the study information 2021/10/01
Last modified on 2023/04/03 14:47:20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Long-term functional prognostic study of Coronavirus disease - 2019 (COVID-19) infection

Acronym

Long-term functional prognostic study of Coronavirus disease - 2019 (COVID-19) infection

Scientific Title

Long-term functional prognostic study of Coronavirus disease - 2019 (COVID-19) infection

Scientific Title:Acronym

Long-term functional prognostic study of Coronavirus disease - 2019 (COVID-19) infection

Region

Japan


Condition

Condition

Coronavirus disease - 2019(COVID-19) infection

Classification by specialty

Pneumology Infectious disease Intensive care medicine
Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to investigate the dysfunction (respiration, mental and physical function) caused by COVID-19 infection for one year, and to clarify the relationship between the duration and severity of the disorder.

Basic objectives2

Others

Basic objectives -Others

Patients with COVID-19 infection

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Exercise tolerance at hospital discharge, and 1 month, 3 months, 6 months, and 1 year after discharge

Key secondary outcomes

Social regression, health-related QOL, cognitive function, mental status, muscle strength, MRS score, O2 inhalation, gait speed


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Hospitalized patients

Key exclusion criteria

Inability to walk before admission, patients diagnosed with the cognitive disorder before admission, patients diagnosed with the psychological disease before admission.

Target sample size

270


Research contact person

Name of lead principal investigator

1st name Tomotaka
Middle name
Last name Koike

Organization

Kitasato university hospital

Division name

Intensive care center

Zip code

2520329

Address

Kitasato 1-15-1, Minami-ku, Sagamihara city, Kanagawa, Japan

TEL

0427788111

Email

tkoike@kitasato-u.ac.jp


Public contact

Name of contact person

1st name Tomotaka
Middle name
Last name Koike

Organization

Kitasato university hospital

Division name

Intensive care center

Zip code

2520329

Address

Kitasato 1-15-1, Minami-ku, Sagamihara city, Kanagawa, Japan

TEL

0427788111

Homepage URL


Email

tkoike@kitasato-u.ac.jp


Sponsor or person

Institute

Kitasato university

Institute

Department

Personal name



Funding Source

Organization

Kitasato university

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kitasato University Medical Ethics Organization(KMEO)

Address

Kitasato 1-15-1, Minami-ku, Sagamihara city, Kanagawa, Japan

Tel

0427788111

Email

rinrib@med.kitasato-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 10 Month 01 Day


Related information

URL releasing protocol

https://pubmed.ncbi.nlm.nih.gov/35443966/

Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2021 Year 03 Month 15 Day

Date of IRB

2021 Year 03 Month 15 Day

Anticipated trial start date

2021 Year 04 Month 01 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Non


Management information

Registered date

2021 Year 09 Month 27 Day

Last modified on

2023 Year 04 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051988